Supply of centrally procured Rebif pre-filled syringes
key details
| Value | £101,230 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 7 May 2020 |
| Contract start | 11 May 2020 |
| Contract end | 29 May 2020 |
| Procedure | limited |
| SME suitable | Yes |
| OCID | ocds-b5fd17-f30fb3d2-ef46-4fd6-9ab1-8370cc5df340 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Merck Serono Ltd | £101,230 | 7 May 2020 | active |
description
please note this is an award notice not an opportunity
The Department of Health & Social Care (the 'Authority') has awarded a contract to Merck Serono Ltd for the supply of pharmaceutical products (Rebif pre-filled syringes - 22mcg) for the purposes of covid-19 related trials.
Due to urgent nature of the requirement Regulation 32 was applied to the requirement in order to secure the products.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Sept 2020 | Award (award) | · | df9221a2-2122-4df6-9127-4542176601f5-381286 |
more from DEPARTMENT OF HEALTH AND SOCIAL CARE
- DHSC: Request for Information - Ambulance Radio Programme (ARP) Network Infrastructure Services · 13 Nov 2024
- Supply of Personal Protective Equipment for Healthcare Workers for the Care of Patients with Suspected or Confirmed Novel Coronavirus (COVID-19) · £19,000,000 · 1 Nov 2023
- Supply of Personal Protective Equipment for Healthcare Workers for the Care of Patients with Suspected or Confirmed Novel Coronavirus (COVID-19) · £20,250,000 · 1 Nov 2023
- Deloitte - Consultancy Project · £366,122 · 7 Oct 2021
- Provision of Lateral Flow Device Digital Reader Solution · £6,500,000 · 24 Sept 2021
- Real-time Assessment of Community Transmission (REACT) Participant Communication and Recruitment · £18,424,740 · 1 Sept 2021
- Penetration Testing · £893,000 · 18 Aug 2021
- Accessibility Audit Services · £33,163 · 18 Aug 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.